How GI side effects quietly sabotage intimacy This section addresses the elephant in the room that nobody wants to discuss
According to clinical trial data from the STEP trials, 43.9% of patients taking semaglutide 2.4 mg experienced nausea at some point during treatment, with the majority of episodes occurring during or immediately after dose increases
these were SUSTAIN 1, 2, 3, 6, and SUSTAIN-Japan [13,14,15, 19, 20]
Heres how Wegovy compares to other drugs in its class: Wegovy Wegovy is approved specifically for chronic weight management and contains the same active ingredient (semaglutide) as Ozempic
Oral semaglutide vs sitagliptin: efficacy by baseline HbA1c and background OAD in PIONEER 3